“…Therefore, manipulation with ploidy, as a biotechnological tool, could be useful in improving pharmaceutical value of medicinal plants, since synthetic autopolyploids usually exhibit increases in bioactive metabolite concentration compared to their diploid progenitors (Javadian et al, 2017;Kong et al, 2017;Lavania et al, 2012;Sadat Noori et al, 2017;Tavan et al, 2015;Xu et al, 2014). However, several studies have shown that polyploidization did not affect the metabolite production (Hull-Sanders et al, 2009;Wohlmuth et al, 2005) or even that the effect of polyploidy on the production of specialized metabolites was negative (Caruso et al, 2013;Cohen et al, 2013;Mansouri and Bagheri, 2017;Tan et al, 2017). Furthermore, in comparison with diploids, polyploids generally produce larger cells which can result in an increased size of plant structures such as leaves, flowers and fruit, increased biomass and often show greater resistance to biotic and abiotic stress (Lavania et al, 2012;Yildiz, 2013).…”